Ordena

Cercar

01/08/2021 Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity
Wang, XJ, Villa, C, Dobarganes, Y, Olveira, C, Giron, R, Garcia-Clemente, M, Maiz, L, Sibila, O, Golpe, R, Menendez, R, Rodriguez-Lopez, J, Prados, C, Martinez-Garcia, MA, Rodriguez, JL, de la Rosa, D, Duran, X, Garcia-Ojalvo, J, Barreiro, E. Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity. International Journal of Environmental Research and Public Health. 2021; 18(16)DOI:10.3390/ijerph18168431. PMID:34444179. IF:4.614(Q1/3D).
01/08/2021 Chronic bronchial infection and incident cardiovascular events in chronic obstructive pulmonary disease patients: A long-term observational study
Martinez-Garcia, MA, Faner, R, Oscullo, G, la Rosa-Carrillo, D, Soler-Cataluna, JJ, Ballester, M, Muriel, A, Agusti, A. Chronic bronchial infection and incident cardiovascular events in chronic obstructive pulmonary disease patients: A long-term observational study. RESPIROLOGY. 2021; 26(8)DOI:10.1111/resp.14086. PMID:34002922. IF:6.175(Q1/3D).
01/08/2021 Multidisciplinary consensus on sputum induction biosafety during the COVID-19 pandemic
Crespo-Lessmann, A, Plaza, V. Multidisciplinary consensus on sputum induction biosafety during the COVID-19 pandemic. ALLERGY. 2021; 76(8)DOI:10.1111/all.14697. PMID:33314245. IF:14.710(Q1/1D).
01/08/2021 Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial
Rojas, J, de Lazzari, E, Negredo, E, Domingo, P, Tiraboschi, J, Ribera, E, Abdulghani, N, Puig, J, Mateo, MG, Podzamczer, D, Gutierrez, MM, Paredes, R, Clotet, B, Gatell, JM, Blanco, JL, Martinez, E, DOLAM Study Grp. Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial. Lancet HIV. 2021; 8(8)DOI:10.1016/S2352-3018(21)00100-4. PMID:34358497. IF:16.070(Q1/1D).
01/08/2021 Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM)
Jimenez-Labaig, P, Pacheco-Barcia, V, Cebria, A, Galvez, F, Obispo, B, Paez, D, Quilez, A, Quintanar, T, Ramchandani, A, Remon, J, Rogado, J, Sanchez, DA, Sanchez-Canovas, M, Sanz-Garcia, E, Sesma, A, Tarazona, N, Cotes, A, Gonzalez, E, Bosch-Barrera, J, Fernandez, A, Felip, E, Vera, R, Rodriguez-Lescure, A, Elez, E. Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM). ESMO Open. 2021; 6(4)DOI:10.1016/j.esmoop.2021.100215. PMID:34325108. IF:6.883(Q1/3D).
01/08/2021 Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations
Wilson, BE, Desnoyers, A, Nadler, MB, Tibau, A, Amir, E. Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations. Cancer Medicine. 2021; 10(16)DOI:10.1002/cam4.4029. PMID:34323019. IF:4.711(Q2/5D).